6-Methoxyindole structure
|
Common Name | 6-Methoxyindole | ||
|---|---|---|---|---|
| CAS Number | 3189-13-7 | Molecular Weight | 147.174 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 297.8±13.0 °C at 760 mmHg | |
| Molecular Formula | C9H9NO | Melting Point | 90-92 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 109.2±10.1 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
| Name | 6-Methoxyindole |
|---|---|
| Synonym | More Synonyms |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 297.8±13.0 °C at 760 mmHg |
| Melting Point | 90-92 °C(lit.) |
| Molecular Formula | C9H9NO |
| Molecular Weight | 147.174 |
| Flash Point | 109.2±10.1 °C |
| Exact Mass | 147.068420 |
| PSA | 25.02000 |
| LogP | 2.00 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.637 |
| Storage condition | Keep Cold |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi:Irritant |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2933990090 |
| Precursor 9 | |
|---|---|
| DownStream 10 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
J. Med. Chem. 54 , 5320, (2011) Tryptophan catabolism mediated by indoleamine 2,3-dioxygenase (IDO) is an important mechanism of peripheral immune tolerance contributing to tumoral immune resistance. IDO inhibition is thus an active... |
|
|
Discovery of a novel class of PPARdelta partial agonists.
Bioorg. Med. Chem. Lett. 18 , 5018, (2008) Anthranilic acid GW9371 was identified as a novel class of PPARdelta partial agonist through high-throughput screening. The design and synthesis of SAR analogues is described. GSK1115 and GSK7227 show... |
|
|
Synthesis and evaluation of 3-aroylindoles as anticancer agents: metabolite approach.
J. Med. Chem. 52 , 4941, (2009) BPR0L075 (2) is a potential anticancer drug candidate designed from Combretastatin A-4 (1) based on the bioisosterism principle. Metabolites of 2, proposed from in vitro human microsome studies, were ... |
| indole, 6-methoxy- |
| EINECS 221-689-6 |
| 6-methoxy-indole |
| 5-Methoxyindole,~ |
| 6-MeO-indole |
| 6-Methoxyindole |
| Methoxyindole |
| 6-Methoxy-1H-indole |
| 6-methoxylindole |
| MFCD00022780 |
| 1H-Indole, 6-methoxy- |